Daewon Pharmaceutical Co., Ltd.
Research Daewon Pharmaceutical Co., Ltd. (003220.KS) on Bullrun: market cap KRW 168.90B, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker003220.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 168.90B
- Dividend yield3.2%
- Financial periodQ2 2026
- RevenueKRW 152.83B
- Net incomeKRW 4.03B
- Free cash flow-KRW 8.54B
- Gross margin46.4%
Valuation Snapshot
latest market cap is KRW 168.90B; dividend yield is 3.2%.
Peer valuation comparison
Latest dividend yield is 3.16% versus a Healthcare sector median of 2.4% (31.7% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 168.90B | n/a | 3.2% | 250 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 250 KRW, yield 3.2%.
About Daewon Pharmaceutical Co., Ltd.
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria;
ETFs that hold Daewon Pharmaceutical Co., Ltd.
US-listed ETFs
Daewon Pharmaceutical Co., Ltd. is held by 7 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | <0.01% | 0.43% |
| State Street SPDR S&P International Small Cap ETF (GWX) | 0.01% | 0.40% |
| Dimensional Emerging Markets ex China Core Equity ETF (DEXC) | <0.01% | 0.43% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Daewon Pharmaceutical Co., Ltd.'s market cap?
Daewon Pharmaceutical Co., Ltd.'s market capitalization is KRW 168.90B.
Does Daewon Pharmaceutical Co., Ltd. pay a dividend?
Daewon Pharmaceutical Co., Ltd. has a dividend yield of 3.2%.
What does Daewon Pharmaceutical Co., Ltd. do?
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use.